SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq:LJPC) reported a net loss for the three months ended June 30, 2007 of $13.5 million, or $0.34 per share (on 39.3 million weighted-average shares), compared to a net loss of $9.3 million, or $0.29 per share (on 32.5 million weighted-average shares), for the same period in 2006. The Company reported a net loss for the six months ended June 30, 2007 of $25.4 million, or $0.70 per share (on 36.0 million weighted-average shares), compared to a net loss of $20.2 million, or $0.62 per share (on 32.5 million weighted-average shares), for the same period in 2006.
